It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

These growth stocks come from two very different industries. Eli Lilly is riding the GLP-1 drug wave, but there is much more ...

The AP-NORC poll shows about half of Americans “strongly” or “somewhat” favor having the federal programs Medicare and Medicaid cover weight-loss drugs for people who have obesity, while about 2 in 10 ...

Find out how Ozempic, Mounjaro, and other medicines are helping to revolutionise weight loss around the world... and how much ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Advertisement Article continues below this ad The Food and Drug Administration’s approval ... Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in ...

The problem is that the drug giant provided fourth-quarter revenue guidance that was below Wall Street expectations, citing disappointing sales of its diabetes and obesity drugs, Mounjaro and ...